Working… Menu

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) (JET-HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02029157
Recruitment Status : Completed
First Posted : January 7, 2014
Last Update Posted : October 9, 2017
Information provided by (Responsible Party):
Kyowa Kirin Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2017
Actual Study Completion Date : August 2017